May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Semaphorin 7A Involvement in Corneal Neovascularization
R.C. Ghanem; F.M. Tobaigy; E. Albe; J.–H. Chang; D.T. Azar
Author Affiliations & Notes
  • R.C. Ghanem
    Ophthalmology Department, Massachusetts Eye and Ear Infirmary – Schepens Eye Research Institute – Harvard Medical School, Boston, MA
  • F.M. Tobaigy
    Ophthalmology Department, Massachusetts Eye and Ear Infirmary – Schepens Eye Research Institute – Harvard Medical School, Boston, MA
  • E. Albe
    Ophthalmology Department, Massachusetts Eye and Ear Infirmary – Schepens Eye Research Institute – Harvard Medical School, Boston, MA
  • J.–H. Chang
    Ophthalmology Department, Massachusetts Eye and Ear Infirmary – Schepens Eye Research Institute – Harvard Medical School, Boston, MA
  • D.T. Azar
    Ophthalmology Department, Massachusetts Eye and Ear Infirmary – Schepens Eye Research Institute – Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships  R.C. Ghanem, None; F.M. Tobaigy, None; E. Albe, None; J. Chang, None; D.T. Azar, None.
  • Footnotes
    Support  NIH Grant EY10101, NIH Grant EY14048
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1643. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Semaphorin 7A Involvement in Corneal Neovascularization
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      R.C. Ghanem, F.M. Tobaigy, E. Albe, J.–H. Chang, D.T. Azar; Semaphorin 7A Involvement in Corneal Neovascularization . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1643.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : Semaphorin 7A (Sema7A), a GPI–membrane–anchored semaphorin, previously known for its immunomodulatory and neuronal effects, may mediate vascular growth. The aim of this study is to investigate the presence of Sema7A in fetal and newborn wild type (WT) mouse eyes, normal adult mouse corneas, and adult mouse corneas with bFGF–induced–vascularization.

Methods: : Sema7A expression was assessed by confocal immunohistochemical staining with anti–mouse Sema7A antibody. Using naked Sema7A cDNA constructs injected to the central corneal stroma, the angiogenic properties of Sema7A were evaluated in an in vivo mouse corneal assay.

Results: : Sema7A was not expressed during development, in newborn or adult eyes of WT mice. Corneas with bFGF–induced neovascularization, however, showed positive expression of Sema7A. Naked cDNA constructs of Sema7A resulted in increased neovascularization as compared to the controls. These increases were not significant at days 3 (0.1 mm2 vs. 0.05 mm2; P=0.39) and 7 (0.49 mm2 vs. 0.06 mm2; P=0.12). They were statistically significant at day 10 (1.8 mm2 vs. 0.11 mm2; P<0.02).

Conclusions: : Sema7A was specifically expressed in vascularized corneas and showed delayed pro–angiogenic properties in our corneal model. These findings suggest a previously unknown role of Sema7A in corneal neovascularization.

Keywords: cornea: basic science • neovascularization 
© 2006, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept